Mr. Kåre Schultz is a President & Chief Executive Officer at Lundbeck Pharma A/S and a President, Chief Executive Officer & Director at Teva Pharmaceutical Industries Ltd.
He is on the Board of Directors at LEGO A/S, Teva Pharmaceutical Industries Ltd. and Danfoss A/S. Mr. Schultz was previously employed as a President & Chief Executive Officer by H. Lundbeck A/S, a Chairman by Royal Unibrew A/S, and a President & Chief Operating Officer by Novo Nordisk A/S.
He also served on the board at Bitten og Mads Clausens Fond, LEGO Holding A/S and LEGO System A/S.
He received his graduate degree from the University of Copenhagen.